Implications of Helicobacter pylori serological titer for the histological severity of antral gastritis

Endoscopy

Volumn 29, Issue 1, 1997, Pages 27-30

  Sheu, B S ^a   Shiesh, S C ^b   Yang, H B ^c   Su, I J ^c   Chen, C Y ^a   Lin, X Z ^a,c  

^a Division of Gastroenterology   (Taiwan)

^b Dept of Medical Technology ^*  (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

UREASE;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPEPSIA; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH ANTRUM; STOMACH ULCER;

EID: 0031057931     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004057     Document Type: Article

References (25)

1. Graham DY, Go MF. Helicobacter pylori: current status. Gastroenterology 1993; 105: 279-82.
2. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med 1993; 328: 349-50.
3. Dooley CP, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108: 70-9.
4. Stolte M, Eidt S. Healing gastric MALT lymphoma by eradicating H. pylori? Lancet 1993; 342: 568.
5. Tatsuta M, Iishi H, Okuda S, et al. The association of Helicobacter pylori with differentiated-type early gastric cancer. Cancer 1993; 72: 1841-5.
6. Forman D, Coleman M, Debacker G, et al. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
7. Gray SF, Wyatt JI, Rathbone BJ. Simplified technique for identifying Campylobacter pyloridis. J Clin Pathol 1986; 39: 1279.
8. Price AB, Levis J, Dolby JM, et al. Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut 1985; 26: 1183-8.
9. Sobala GM, Crabtree JE, Pentith JA, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94-6.
10. Kosunen TU, Seppälä K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893-5.
11. Culter A, Schubert A, Schubert T. Role of Helicobacter pylori serology evaluation treatment success. Dig Dis Sci 1993; 38: 2262-6.
12. Cullen DJE, Cullen KJ, Collin BJ, et al. Serological assessment of Helicobacter pylori eradication. Lancet 1992; 340: 1161-2.
13. Mendall MA, Goggin PM, Marrero JM, et al. Helicobacter pylori screening prior to endoscopy. Eur J Gastroenterol Hepatol 1992; 4: 717-9.
14. Mendall MA, Jazrawi RP, Marrero JM, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995; 36: 330-3.
15. The EUROGAST study group. Epidemiology of, and risk factors for. Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-6.
16. Alam K, Schubert TT, Bologna SD, et al. Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am J Gastroenterol 1992; 87: 424-8.
17. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
18. Veenendaal RA, Peña AS, Meijer JL, et al. Long-term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 1291-4.
19. Lin JT, Wang JT, Wang TH, et al. Helicobacter pylori infection in early and advanced gastric adenocarcinoma: a seroprevalence study in 143 Taiwanese patients. Hepato-Gastroenterology 1993; 40: 596-9.
20. Glupczynishi Y. Methodological aspects of serology for the diagnosis of H. pylori infection. Eur J Gastroenterol Hepatol 1993; 5 (Suppl 2): 50-3.
21. Newell DG, Johnston BJ, Ali MH, et al. An enzyme-linked immunosorbent assay for the serodiagnosis of Campylobacter pylori-associated gastritis. Scand J Gastroenterol 1988; 23: (Suppl 142): 53-7.
22. Perez-Perez GI, Dworkin BM, Chodos JE, et al. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11-7.
23. Jones DM, Lessells AM, Eldridge J. Campylobacter-like organisms on the gastric mucosa: culture, histologic, and serologic studies. J Clin Pathol 1984; 37: 1002-6.
24. Sheu BS, Lin CY, Lin XZ, et al. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol 1996; 91: 441-7.
25. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993; 88: 505-9.